Pistacia lentiscus Hydrosol: Untargeted Metabolomic Analysis and Anti-Inflammatory Activity Mediated by NF-κB and the Citrate Pathway

Abstract EN

Pistacia lentiscus shows a long range of biological activities, and it has been used in traditional medicine for treatment of various kinds of diseases.

Moreover, related essential oil keeps important health-promoting properties.

However, less is known about P.

lentiscus hydrosol, a main by-product of essential oil production, usually used for steam distillation itself or discarded.

In this work, by using ultra-high-resolution ESI(+)-FT-ICR mass spectrometry, a direct identification of four main classes of metabolites of P.

lentiscus hydrosol (i.e., terpenes, amino acids, peptides, and condensed heterocycles) was obtained.

Remarkably, P.

lentiscus hydrosol exhibited an anti-inflammatory activity by suppressing the secretion of IL-1β, IL-6, and TNF-α proinflammatory cytokines in lipopolysaccharide- (LPS-) activated primary human monocytes.

In LPS-triggered U937 cells, it inhibited NF-κB, a key transcription factor in inflammatory cascade, regulating the expression of both the mitochondrial citrate carrier and the ATP citrate lyase genes.

These two main components of the citrate pathway were downregulated by P.

lentiscus hydrosol.

Therefore, the levels of ROS, NO, and PGE2, the inflammatory mediators downstream the citrate pathway, were reduced.

Results shed light on metabolic profile and anti-inflammatory properties of P.

lentiscus hydrosol, suggesting its potential as a therapeutic agent.